India Animal Vaccine Market By Animal Type, By Technology, By Disease, By Route of Administration, By Distribution Channel, Competition, Forecast & Opportunities, FY 2026

The Indian Animal Vaccine Market is projected to reach 232 million by FY 2026. India is the fourth largest chicken producer in the world and is among the leading exporters of high quality poultry products to various countries. Besides, India is also the third largest producer of eggs and per capita availability of eggs is increasing on year-on-year basis in the country. Thus, with the increase in the availability of chicken, eggs and other poultry products, the requirement of maintaining the quality and health of these products has increased, which has led to the growth in the animal vaccine market. Another major factor that has contributed to the market growth is the increasing number of diseases in animals such as rabies, coccidiosis, swine pneumonia and many others. The market is also gaining traction due to the increasing government initiatives. One of the recent government initiatives was the announcement of National Animal Disease Control Programme with a total outlay of around USD1.8 billion (INR 13,343 crore). The sole motive of the programme is 100% vaccination of 530 million animals including buffalos, sheep, pigs, etc., all over the country and eradication of livestock diseases by FY 2030.

The Indian Animal Vaccine Market is segmented on the basis of animal type, technology, disease, route of administration, distribution channel, and region. Based on animal type the market is further segmented into livestock, swine, poultry, companion animals, and others. Amongst these, livestock segment dominated the market in FY 2020 and the segment is expected to continue its dominance during the forecast period. India is one of the top producers of chicken and eggs in the world.

Major companies in the Indian Animal Vaccine Market include Zoetis, Inc., Elanco India Private Limited, Merck & Co., Inc., Ceva Sante Animale SA, Bio-med Inc, Globion India Private Limited, Biovet Private Limited, Brilliant Bio Pharma Pvt Ltd, Hester Biosciences Limited, Indovax Pvt. Ltd., among others.

Years considered for this report:

• Historical Years: FY2016 - FY2019
• Base Year: FY2020
• Estimated Year: FY2021
• Forecast Period: FY2022 - FY2026

The Objective of the Study:

• To analyze and estimate the market size of the Indian Animal Vaccine Market from FY2016 to FY2020.
• To estimate and forecast the market size of the Indian Animal Vaccine Market from FY2021 to FY2026.
• To classify and forecast the Indian Animal Vaccine Market based on animal type, technology, disease, route of administration, distribution channel, region, and company.
• To identify dominant region or segment in the Indian Animal Vaccine Market.
• To identify drivers and challenges for the Indian Animal Vaccine Market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Indian Animal Vaccine Market.
• To conduct pricing analysis for the Indian Animal Vaccine Market.
• To identify and analyze the profile of leading players operating in the Indian Animal Vaccine Market.
• To identify key sustainable strategies adopted by market players in the Indian Animal Vaccine Market.

The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of manufacturers across the country. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the manufacturers which could not be identified due to the limitations of secondary research. The publisher analyzed the manufacturers, distribution channels and presence of all major players across the country.

The publisher calculated the market size of the Indian Animal Vaccine Market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:

• Animal vaccine manufacturers, suppliers, distributors and other stakeholders
• Government bodies such as regulating authorities and policy makers
• Organizations, forums, and alliances related to animal vaccine
• Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as vaccine manufacturers, end-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope:
In this report, the Indian Animal Vaccine Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Market, By Animal Type:

• Livestock
• Swine
• Poultry
• Companion Animals
• Others

Market, By Technology:

• Inactive Vaccine
• Live Attenuated Vaccine
• Toxoid Vaccine
• Recombinant Vaccine
• Others

Market, By Disease:

• Foot and Mouth Disease
• New Castle Disease
• Infectious Bronchitis
• Infectious Bursal Disease
• Fowl Pox
• Rabies
• Others

Market, By Route of Administration:

• Subcutaneous
• Intramuscular
• Intraocular
• Oral
• Others

Market, By Distribution Channel:

• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies

Market, By Region:

• North
• East
• West
• South

Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Indian Animal Vaccine Market.

Available Customizations:
With the given market data, the publisher offers customizations according to a client’s specific needs.